RECURRENT CANCER
Clinical trials for RECURRENT CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug IMA401 takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a new drug called IMA401, which helps the immune system attack cancer cells. It is for adults with advanced solid tumors (like lung or head and neck cancer) that have come back or stopped responding to treatment. The study checks safety, the right dos…
Matched conditions: RECURRENT CANCER
Phase: PHASE1 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
Promising cancer combo study pulled before it began
Knowledge-focused TerminatedThis study aimed to see if adding special nanoparticles to proton therapy could help people with recurrent cancer that had already been treated with radiation. It was designed for adults with certain tumors in the head, spine, or pelvis. However, the study was withdrawn before an…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC